---
$id: https://graph.org.ai/products/commodity/51111621
$type: Product
source: UNSPSC
code: "51111621"
title: "Acivicin"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acivicin

**UNSPSC Code**: 51111621
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a glutamine amidotransferase inhibitor with the molecular formula C5H7ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0X60K76I6, chemically known as 5-isoxazoleacetic acid, alpha-amino-3-chloro-4,5-dihydro-, (s-(r*,r*))- but generally known as acivicin, which bears US NIH Compound Identifier 2007. European Medicines Agency schedules Acivicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05241MIG. The term ACIVICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). ACIVICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acivicin under HS 29349990 and SITC 51579. As of Q4 2014, ACIVICIN remains the US FDA Preferred Term for this commodity. Acivicin bears US NLM identifiers UMLS ID C0050560 and NCI Concept Code C986. SMILES: CLC1=NOC(C(N)C(=O)O)C1.

